Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 91-99

  Campos Toimil, Manuel ^a   Elíes, Jacobo ^a   Álvarez, Ezequiel ^b   Verde, Ignacio ^b   Orallo, Francisco ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

A7r5; Calcium; Fura 2; Patch clamp; Resveratrol

Indexed keywords

ANGIOTENSIN II; ARGIPRESSIN; CALCIUM; POTASSIUM; RESVERATROL; RYANODINE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR CALCIUM; INCUBATION TIME; ISOMERISM; MUSCLE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARGININE VASOPRESSIN; BLOOD VESSELS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELL LINE; FLUORESCENT DYES; FURA-2; MEMBRANE POTENTIALS; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; RATS; RYANODINE; STEREOISOMERISM; STILBENES;

EID: 35548936868     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.003     Document Type: Article

References (37)

1. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840
2. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
3. 2+ buffering and coupling to AVP-evoked inositol phosphate synthesis. Am. J. Physiol 266 (1994) C276-C283
4. Burjonroppa, S., Fujise, K., 2006. Resveratrol as cardioprotective agent: evidence from bench and bedside. In: Aggarwal, B.B., Shishodia, S. (Eds.), Resveratrol in Health and Disease. CRC Press, Taylor & Francis Group LLC, Boca Raton, FL, USA, pp. 539-555.
5. 2+ stores. J. Biol. Chem. 268 (1993) 6945-6952
6. 2+ efflux in A7r5 rat smooth muscle cells. J. Physiol 485 Pt 2 (1995) 455-468
7. 2+ channels in vascular smooth muscle cells. Life Sci. 80 (2007) 2147-2153
8. Campos-Toimil M., Elíes J., and Orallo F. Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol. Nutr. Food Res. 49 (2005) 396-404
9. Campos-Toimil, M., Elíes, J., Orallo, F., in press. Cardiovascular effects of trans- and cis-resveratrol. In: Singh, V.K., Govil, J.N., (Eds.), Recent Progress in Medicinal Plants Vol. 21: Phytopharmacology and Therapeutic Values III. Stadium Press LLC, Houston, USA.
10. Chen C.K., and Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol. 27 (1996) 363-366
11. Chen W.P., Su M.J., and Hung L.M. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur. J. Pharmacol. 554 (2007) 196-204
12. Fitzpatrick D.F., Hirschfield S.L., and Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 265 (1993) H774-H778
13. i transients in myocytes from guinea-pig urinary bladder. J. Physiol 458 (1992) 119-137
14. Griendling K.K., Ushio-Fukai M., Lassegue B., and Alexander R.W. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29 (1997) 366-373
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
16. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391 (1981) 85-100
17. Hughes A.D., and Schachter M. Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5). Cell Calcium 15 (1994) 317-330
18. 2+ release in contractions of intact vascular smooth muscles. Am. J. Physiol 261 (1991) H1464-H1470
19. Jung S., Strotmann R., Schultz G., and Plant T.D. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am. J. Physiol Cell Physiol 282 (2002) C347-C359
20. 2+ release mechanism in A7r5 cells regulated by calmodulin-like proteins. J. Biol. Chem. 278 (2003) 27548-27555
21. Leiro J., Álvarez E., Arranz J.A., Laguna R., Uriarte E., and Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 75 (2004) 1156-1165
22. Liu Z., Song Y., Zhang X., Liu Z., Zhang W., Mao W., Wang W., Cui W., Zhang X., Jia X., Li N., Han C., and Liu C. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin. Exp. Pharmacol. Physiol. 32 (2005) 1049-1054
23. Liu Z., Zhang L.P., Ma H.J., Wang C., Li M., and Wang Q.S. Resveratrol reduces intracellular free calcium concentration in rat ventricular myocytes. Sheng Li Xue. Bao. 57 (2005) 599-604
24. Missiaen L., Parys J.B., De Smedt H., Himpens B., and Casteels R. Inhibition of inositol trisphosphate-induced calcium release by caffeine is prevented by ATP. Biochem. J. 300 Pt 1 (1994) 81-84
25. Mizutani K., Ikeda K., Kawai Y., and Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. (Tokyo) 46 (2000) 78-83
26. 2+-release mechanism in A7r5 cells. Mol. Pharmacol. 68 (2005) 241-250
27. 2+ currents in aortic smooth muscle cells. Eur. J. Pharmacol. 294 (1995) 625-635
28. Orallo, F., 2006a. Biological effects of Cis- versus Trans-resveratrol. In: Aggarwal, B.B., Shishodia, S. (Eds.), Resveratrol in Health and Disease. CRC Press, Taylor & Francis Group LLC, Boca Raton, FL, USA, pp. 577-600.
29. Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem. 13 (2006) 87-98
30. Orallo F., and Camiña M. Study of the endothelium-dependent and endothelium-independent vasodilator effects of resveratrol in rat aorta. Br. J. Pharmacol. 124 (1998) 108
31. Orallo F., Álvarez E., Camiña M., Leiro J.M., Gómez E., and Fernández P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 61 (2002) 294-302
32. Putney Jr. J.W. Capacitative calcium entry revisited. Cell Calcium 11 (1990) 611-624
33. Soleas G.J., Diamandis E.P., and Goldberg D.M. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30 (1997) 91-113
34. Thibonnier M., Bayer A.L., Simonson M.S., and Kester M. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129 (1991) 2845-2856
35. 2+ current in rat ventricular myocytes. Br. J. Pharmacol. 127 (1999) 65-74
36. Wang G.J., Wu X.C., Chen C.F., Lin L.C., Huang Y.T., Shan J., and Pang P.K. Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells. J. Pharmacol. Exp. Ther. 289 (1999) 1237-1244
37. Zhang L.P., Yin J.X., Liu Z., Zhang Y., Wang Q.S., and Zhao J. Effect of resveratrol on L-type calcium current in rat ventricular myocytes. Acta Pharmacol. Sin. 27 (2006) 179-183